The company's laser technology will facilitate the accurate measurement of oxygen levels for patients with darker skin ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive ...

Cruz announces that investors with losses related to Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN ...

Looking ahead, Zynex has offered a muted revenue guidance of $27 million for the second quarter of 2025, with an anticipated EPS loss of $0.20. The company has withheld full-year guidance pending ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

Good afternoon, ladies and gentlemen, and welcome to the Zynex First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen only mode. A question-and-answer session ...

Zynex (Nasdaq:NYXI) announced today that it submitted its NiCO non-invasive co-oximeter device for FDA 510(k) clearance.

ZYXI Investors with Losses Encouraged to Contact the Firm Before May 19th DeadlineSAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- Medical t ...

(RTTNews) - Zynex, Inc. (ZYXI), a medical technology company, Monday announced it has submitted a 510(k) application to the U.S. Food and Drug Administration for its NiCO, Noninvasive CO-Oximeter ...

ENGLEWOOD, Colo., May 12, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...